
Auteur A. ENGLUND
|
Documents disponibles écrits par cet auteur (4)

K. R. THOMSEN ; C. LINDHOLST ; B. THYLSTRUP ; S. KVAMME ; L. A. REITZEL ; M. WORM-LEONHARD ; A. ENGLUND ; T. P. FREEMAN ; M. HESSE | 2019
Dans Experimental and Clinical Psychopharmacology (Vol.27, n°4, August 2019) Article : PériodiqueGlobally, recent studies report increases in Delta-9-tetrahydrocannabinol (THC) concentration in seized samples of cannabis for human consumption. This is important, because use of cannabis with a high concentration of THC has been linked to a n[...]
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
RapportENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]
V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN | 2022
Dans Addiction (Vol.117, n°6, June 2022) Article : PériodiqueBACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]
R. M. MURRAY ; H. QUIGLEY ; D. QUATTRONE ; A. ENGLUND ; M. DI FORTI | 2016
Dans World Psychiatry (Vol.15, n°3, October 2016) Article : PériodiqueEpidemiological evidence demonstrates that cannabis use is associated with an increased risk of psychotic outcomes, and confirms a dose-response relationship between the level of use and the risk of later psychosis. High-potency cannabis and syn[...]